Perceptive Advisors LLC Tg Therapeutics, Inc. Transaction History

Perceptive Advisors LLC

  • $3.83 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$25.27 - $54.9 $856,476 - $1.86 Million
-33,893 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$18.49 - $27.24 $76,382 - $112,528
4,131 Added 13.88%
33,893 $907,000
Q2 2020

Aug 14, 2020
BUY
$8.9 - $21.84 $264,881 - $650,002
29,762 New
29,762 $580,000
Q3 2018

Nov 14, 2018
SELL
$5.15 - $14.0 $515,000 - $1.4 Million
-100,000 Closed
0 $0
Q2 2018

Nov 01, 2018
BUY
$12.5 - $15.0 $1.25 Million - $1.5 Million
100,000 New
100,000 $258,000

Others Institutions Holding TGTX

# of Institutions
339
Shares Held
88.5M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $5B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email